UNSPSC 51283804: Volpristin

This classification denotes an antibiotic with the molecular formula C28H37N3O7, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 18UAN5144E. The term VOLPRISTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 13 no. 3, 1999, list 42. ). SMILES: CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC(C3)C(=O)OC1C(C)C)O)C.

UNSPSC 51283804 Volpristin is a Commodity code covering pharmaceutical products procured by state and local health agencies. Recent state and local opportunities tagged under this code show actual procurement of naloxone, antimicrobial tablets, and safe drug deactivation systems — reflecting the category's application to medications and medical supplies in public health inventory management. State and local issuing bodies acquiring under the code include state departments of public health and county health departments, with purchases typically structured as multi-year supply contracts with renewal options and quarterly or regular delivery schedules. Procurement vehicles include both traditional competitive bidding and cooperative purchasing arrangements such as MMCAP Infuse consortia, which allow member jurisdictions to leverage existing awarded contracts for pharmaceutical warehouse supplies.

Recent activity spans Florida and Illinois. In June 2026, Seminole County, Florida released an IFB for annual supply of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, closing July 26, 2023; vendors were required to include all shipping and delivery costs and comply with E-Verify and drug-free workplace certification. In August 2026, the Illinois Department of Public Health awarded a three-year piggyback contract through MMCAP Infuse to Chartwell Rx LLC for pharmaceutical warehouse supply including Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, with a total value of $2,999,999.11 across all renewal periods.